Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Lemaitre Vascular (LMAT – Research Report), ...
Nektar Therapeutics has concluded target enrolment in the Phase IIb REZOLVE-AA trial of its investigational biologic therapy, ...
William Blair analyst Andy Hsieh reiterated a Buy rating on Cardiff Oncology (CRDF – Research Report) today. The company’s shares closed today ...
Zacks.com on MSN5h
Recursion Pharmaceuticals (RXRX) Reports Q4 Loss, Lags Revenue EstimatesRecursion Pharmaceuticals (RXRX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.40 per share a year ago. These ...
Burung kolibri, yang di Indonesia akrab disapa sebagai burung madu, adalah mahakarya alam dalam wujud miniatur. Lebih dari ...
Burung Kolibri Ninja, dengan warna-warni bulunya yang memukau dan kelincahannya yang mempesona, adalah primadona di kalangan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback